All Stories

  1. U.S. Tax Credits to Promote Practical Proactive Preventative Care for Parkinson’s Disease
  2. The Functional Role of Thalamocortical Coupling in the Human Motor Network
  3. Effects of a Cycling Dual Task on Emotional Word Choice in Parkinson's Disease
  4. Segmentation of the Globus Pallidus Internus Using Probabilistic Diffusion Tractography for Deep Brain Stimulation Targeting in Parkinson Disease
  5. The Subthalamic Nucleus, Limbic Function, and Impulse Control
  6. Association between antidepressants and falls in Parkinson’s disease
  7. Comparison of Two Methods for Inducing Reflex Cough in Patients With Parkinson’s Disease, With and Without Dysphagia
  8. The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson’s disease
  9. How Should Pushing Off or the Use of Assistive Devices Be Incorporated in the Timed Up and Go for Persons With Parkinson Disease?
  10. Incidence and mortality trends of aspiration pneumonia in Parkinson's disease in the United States, 1979–2010
  11. Abnormal tactile pressure perception in Parkinson’s disease
  12. Novel targets and stimulation paradigms for deep brain stimulation
  13. Capturing patients’ experiences to change Parkinson’s disease care delivery: a multicenter study
  14. High rates of fatigue and sleep disturbances in dystonia
  15. Temporal Lobe and Frontal-Subcortical Dissociations in Non-Demented Parkinson’s Disease with Verbal Memory Impairment
  16. Distinct patterns of brain activity in progressive supranuclear palsy and Parkinson's disease
  17. Rate of aspiration pneumonia in hospitalized Parkinson’s disease patients: a cross-sectional study
  18. Deep brain stimulation targeting the fornix for mild Alzheimer dementia: design of the ADvance randomized controlled trial
  19. Anxiety and Depression Are Better Correlates of Parkinson’s Disease Quality of Life Than Apathy
  20. Update on deep brain stimulation in Parkinson’s disease
  21. Narrative Discourse Cohesion in Early Stage Parkinson’s Disease
  22. The Profile of Long-term Parkinson’s Disease Survivors with 20 Years of Disease Duration and Beyond
  23. Proceedings of the Second Annual Deep Brain Stimulation Think Tank: What's in the Pipeline
  24. Longitudinal changes in free-water within the substantia nigra of Parkinson’s disease
  25. Unexpected Dual Task Benefits on Cycling in Parkinson Disease and Healthy Adults: A Neuro-Behavioral Model
  26. Weight Loss and Impact on Quality of Life in Parkinson’s Disease
  27. Steroid-responsive intracranial germinoma presenting as Holmes’ tremor: Importance of a tissue diagnosis
  28. Missing Dosages and Neuroleptic Usage May Prolong Length of Stay in Hospitalized Parkinson's Disease Patients
  29. Reply: The ‘cognitions’ index of the Parkinson's disease questionnaire-39 relates to sleep disturbances and hallucinations
  30. Clinical Evaluation of Eye Movements in Spinocerebellar Ataxias
  31. Multiple system atrophy is not caused by C9orf72 hexanucleotide repeat expansions
  32. Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study
  33. A Polysomnographic Study of Parkinson’s Disease Sleep Architecture
  34. Latent growth-curve analysis reveals that worsening Parkinson’s disease quality of life is driven by depression.
  35. Chasing Tics in the Human Brain: Development of Open, Scheduled and Closed Loop Responsive Approaches to Deep Brain Stimulation for Tourette Syndrome
  36. Low-frequency Versus High-frequency Subthalamic Nucleus Deep Brain Stimulation on Postural Control and Gait in Parkinson's Disease: A Quantitative Study
  37. Person-Centered Care in the Home Setting for Parkinson’s Disease: Operation House Call Quality of Care Pilot Study
  38. Subthalamic nucleus—sensorimotor cortex functional connectivity in de novo and moderate Parkinson's disease
  39. Tourette syndrome deep brain stimulation: A review and updated recommendations
  40. Pedunculopontine Nucleus Stimulation: Where are We Now and What Needs to be Done to Move the Field Forward?
  41. Acute and Chronic Mood and Apathy Outcomes from a Randomized Study of Unilateral STN and GPi DBS
  42. Outcomes, management, and potential mechanisms of interleaving deep brain stimulation settings
  43. Distinct functional and macrostructural brain changes in Parkinson's disease and multiple system atrophy
  44. Proof of principle: Transformation approach alters caudate nucleus volume and structure-function associations
  45. The Cognition and Emotional Well-being indices of the Parkinson's disease questionnaire-39: What do they really measure?
  46. Comparison of voluntary and reflex cough effectiveness in Parkinson's disease
  47. Decreased Cough Sensitivity and Aspiration in Parkinson Disease
  48. Smile without euphoria induced by deep brain stimulation: a case report
  49. Atrophy and Other Potential Factors Affecting Long Term Deep Brain Stimulation Response: A Case Series
  50. Deep-Brain Stimulation — Entering the Era of Human Neural-Network Modulation
  51. Deep Brain Stimulation for Tourette syndrome: The Current State of the Field
  52. Defining the Clinically Meaningful Difference in Gait Speed in Persons With Parkinson Disease
  53. Five-Months-Postoperative Neuropsychological Outcome From a Pilot Prospective Randomized Clinical Trial of Thalamic Deep Brain Stimulation for Tourette Syndrome
  54. The Rationale Driving the Evolution of Deep Brain Stimulation to Constant-Current Devices
  55. Three families with Perry syndrome from distinct parts of the world
  56. Treatment of advanced Parkinsonʼs disease
  57. Global attentional neglect of segmented lines in Parkinson’s disease
  58. Sequential Voluntary Cough and Aspiration or Aspiration Risk in Parkinson’s Disease
  59. Concordance and Discriminatory Power of Cough Measurement Devices for Individuals With Parkinson Disease
  60. Medicare Coverage of Investigational Devices
  61. Surgical Treatment of Dyskinesia in Parkinson’s Disease
  62. The “Brittle Response” to Parkinson’s Disease Medications: Characterization and Response to Deep Brain Stimulation
  63. Coordinate-Based Lead Location Does Not Predict Parkinson's Disease Deep Brain Stimulation Outcome
  64. Attentional resource allocation and swallowing safety in Parkinson's disease: A dual task study
  65. Consensus-based clinical practice recommendations for the examination and management of falls in patients with Parkinson's disease
  66. Timed Up and Go, Cognitive, and Quality-of-Life Correlates in Parkinson's Disease
  67. Barriers to investigator-initiated deep brain stimulation and device research
  68. Swallowing Outcomes Following Unilateral STN vs. GPi Surgery: A Retrospective Analysis
  69. An Eight-Year Clinic Experience with Clozapine Use in a Parkinson’s Disease Clinic Setting
  70. Increased Precursor Cell Proliferation after Deep Brain Stimulation for Parkinson's Disease: A Human Study
  71. Correlations of apathy and depression with postural instability in Parkinson disease
  72. Mobility, mood and site of care impact health related quality of life in Parkinson's disease
  73. Associations Between Cognitive and Gait Performance During Single- and Dual-Task Walking in People With Parkinson Disease
  74. Cognitive declines after deep brain stimulation are likely to be attributable to more than caudate penetration and lead location
  75. Locomotor adaptation and locomotor adaptive learning in Parkinson’s disease and normal aging
  76. Influence of Hypertension on Neurocognitive Domains in Nondemented Parkinson’s Disease Patients
  77. Detraining outcomes with expiratory muscle strength training in Parkinson disease
  78. Impulsive and Compulsive Behaviors in Parkinson Study Group (PSG) Centers Performing Deep Brain Stimulation Surgery
  79. MRI Reveals Brain Abnormalities in Drug-Naive Parkinson’s Disease
  80. Surgical Options for Levodopa-Induced Dyskinesia in Parkinson’s Disease
  81. Translational Imperatives in Deep Brain Stimulation Research: Addressing Neuroethical Issues of Consequences and Continuity of Clinical Care
  82. Rationale and Clinical Pearls for Primary Care Doctors Referring Patients for Deep Brain Stimulation
  83. Driving Errors in Parkinson's Disease: Moving Closer to Predicting On-Road Outcomes
  84. I spy apraxic eyes in spinocerebellar ataxia type 2: A false-negative ataxia panel
  85. Surgical Neuroanatomy and Programming in Deep Brain Stimulation for Obsessive Compulsive Disorder
  86. Clozapine as a potential treatment for refractory impulsive, compulsive, and punding behaviors in Parkinson’s disease
  87. Unilateral thalamic deep brain stimulation in essential tremor demonstrates long-term ipsilateral effects
  88. Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa?
  89. Deep brain stimulation and ablation for obsessive compulsive disorder: evolution of contemporary indications, targets and techniques
  90. Surgical Treatment of Parkinson’s Disease: Patients, Targets, Devices, and Approaches
  91. Deep brain stimulation (DBS) at the interface of neurology and psychiatry
  92. High rates and the risk factors for emergency room visits and hospitalization in Parkinson's disease
  93. Selective use of low frequency stimulation in Parkinson's disease based on absence of tremor
  94. Intraoperative smile in a multiple sclerosis patient with medication-refractory tremor
  95. Erratum: A closer look at unilateral versus bilateral deep brain stimulation: results of the National Institutes of Health COMPARE cohort
  96. Gait variability magnitude but not structure is altered in essential tremor
  97. Reliability of Three Benton Judgment of Line Orientation Short Forms in Idiopathic Parkinson’s Disease
  98. The history of cerebral PET scanning: From physiology to cutting-edge technology
  99. The Evolving Role of Diffusion Magnetic Resonance Imaging in Movement Disorders
  100. Effect of lead trajectory on the response of essential head tremor to deep brain stimulation
  101. Gait initiation impairments in both Essential Tremor and Parkinson's disease
  102. Swallowing and deep brain stimulation in Parkinson's disease: A systematic review
  103. The temporal pattern of stimulation may be important to the mechanism of deep brain stimulation
  104. Deep Brain Stimulation May Improve Quality of Life in People With Parkinson's Disease Without Affecting Caregiver Burden
  105. Update on Treatment of Essential Tremor
  106. Dystonia, facial dysmorphism, intellectual disability and breast cancer associated with a chromosome 13q34 duplication and overexpression of TFDP1: case report
  107. Variability in clinical phenotypes of heterozygous and homozygous cases ofParkin-related Parkinson's disease
  108. Using the Timed Up & Go Test in a Clinical Setting to Predict Falling in Parkinson's Disease
  109. Cerebral Venous Infarction: A Potentially Avoidable Complication of Deep Brain Stimulation Surgery
  110. Hedonic and behavioral deficits associated with apathy in Parkinson's disease: Potential treatment implications
  111. Neurologist Consistency in Interpreting Information Provided by an Interactive Visualization Software for Deep Brain Stimulation Postoperative Programming Assistance
  112. Stimulation Region Within the Globus Pallidus Does Not Affect Verbal Fluency Performance
  113. The late positive potential, emotion and apathy in Parkinson’s disease
  114. Driving Performance and Behaviors: A Comparison of Gender Differences in Parkinson's Disease
  115. Management of Deep Brain Stimulator Battery Failure: Battery Estimators, Charge Density, and Importance of Clinical Symptoms
  116. The history of cerebral PET scanning: From physiology to cutting-edge technology
  117. Impact of discontinuing tremor suppressing medications following thalamic deep brain stimulation
  118. Deep-Brain Stimulation for Parkinson's Disease
  119. Emerging Subspecialties in Neurology: Deep brain stimulation and electrical neuro-network modulation
  120. Advancing research towards novel therapeutic approaches
  121. A Trial of Scheduled Deep Brain Stimulation for Tourette Syndrome
  122. Differential and Better Response to Deep Brain Stimulation of Chorea Compared to Dystonia in Huntington’s Disease
  123. Interlimb coordination is impaired during walking in persons with Parkinson's disease
  124. Mechanism of action for deep brain stimulation and electrical neuro-network modulation (ENM)
  125. Postural/Gait and Cognitive Function as Predictors of Driving Performance in Parkinson's Disease
  126. The Current State and Needs of North American Movement Disorders Fellowship Programs
  127. The Demise of Poskanzer and Schwab’s Influenza Theory on the Pathogenesis of Parkinson’s Disease
  128. Health comorbidities and cognition in 1948 patients with idiopathic Parkinson's disease
  129. Letter from the Guest Editors
  130. Setting realistic expectations for DBS in dystonia
  131. What are the issues facing Parkinson's disease patients at ten years of disease and beyond?: Data from the NPF-QII study
  132. Population Rate Dynamics and Multineuron Firing Patterns in Sensory Cortex
  133. Emerging Opportunities for Serotypes of Botulinum Neurotoxins
  134. Deep-Brain Stimulation for Parkinson's Disease
  135. Delineation of motor and somatosensory thalamic subregions utilizing probabilistic diffusion tractography and electrophysiology
  136. Rebound symptoms following battery depletion in the NIH OCD DBS cohort: Clinical and reimbursement issues
  137. Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson’s disease
  138. Increased Thalamic Gamma Band Activity Correlates with Symptom Relief following Deep Brain Stimulation in Humans with Tourette’s Syndrome
  139. Systematic procedure for reduction of kinetic mechanisms of complex chemical processes and its software implementation
  140. Quantitative Normative Gait Data in a Large Cohort of Ambulatory Persons with Parkinson’s Disease
  141. Components of Depression in Parkinson Disease
  142. GPi and STN deep brain stimulation can suppress dyskinesia in Parkinson's disease
  143. Taking a Better History for Behavioral Issues Pre- and Post-Deep Brain Stimulation: Issues Missed by Standardized Scales
  144. Neurogenic potential of progenitor cells isolated from postmortem human Parkinsonian brains
  145. An Algorithm for Management of Deep Brain Stimulation Battery Replacements: Devising a Web-Based Battery Estimator and Clinical Symptom Approach
  146. Bone Mineral Density (BMD) in Male Patients with Parkinson's Disease
  147. Improvement of Both Dystonia and Tics With 60 Hz Pallidal Deep Brain Stimulation
  148. Personalized medicine in deep brain stimulation through utilization of neural oscillations
  149. Amantadine: The journey from fighting flu to treating Parkinson disease
  150. Selection of Deep Brain Stimulation Candidates in Private Neurology Practices: Referral May Be Simpler than a Computerized Triage System
  151. Overview of Surgical Treatment Possibilities in Hyperkinetic Disorders
  152. Worsening essential tremor following deep brain stimulation: disease progression versus tolerance
  153. Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites
  154. Postmortem observation of collagenous lead tip region fibrosis as a rare complication of DBS
  155. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial
  156. Effects of STN and GPi Deep Brain Stimulation on Impulse Control Disorders and Dopamine Dysregulation Syndrome
  157. Unravelling the actions of deep brain stimulation: potential role for astrocytes
  158. Carbidopa/levodopa dose elevation and safety concerns in Parkinson's patients: a cross-sectional and cohort design
  159. DBS and Electrical Neuro-Network Modulation to Treat Neurological Disorders
  160. Deep brain stimulation response in pathologically confirmed cases of multiple system atrophy
  161. Dimensions of Apathy in Parkinson's Disease: Exploratory Factor Analysis of the Apathy Scale
  162. Micrographia and related deficits in Parkinson's disease: a cross-sectional study
  163. Mood and motor trajectories in Parkinson's disease: Multivariate latent growth curve modeling.
  164. The Prevalence of Fatigue Following Deep Brain Stimulation Surgery in Parkinson's Disease and Association with Quality of Life
  165. The Transition of Deep Brain Stimulation from Disease Specific to Symptom Specific Indications
  166. Parkinson's disease patients cannot get their dopamine replacement: The 8-sinemet limit
  167. Addiction-Like Manifestations and Parkinson's Disease: A Large Single Center 9-Year Experience
  168. Pedunculopontine Nucleus Stimulation Improves Gait Freezing in Parkinson Disease
  169. Unilateral deep brain stimulation surgery in Parkinson’s disease improves ipsilateral symptoms regardless of laterality
  170. Stem cell pathologies and neurological disease
  171. Evidence-based guideline update: Treatment of essential tremor: Report of the Quality Standards Subcommittee of the American Academy of Neurology
  172. Emotion and ocular responses in Parkinson's disease
  173. Apathy and Depression: Separate Factors in Parkinson's Disease
  174. DBS Candidates That Fall Short on a Levodopa Challenge Test
  175. Unilateral GPi-DBS as a Treatment for Levodopa-Induced Respiratory Dyskinesia in Parkinson Disease
  176. Usefulness of Screening Tools for Predicting Driving Performance in People With Parkinson's Disease
  177. Sustained Dyskinesias Following Elective Cessation and Reactivation of Chronic Subthalamic Nucleus Deep Brain Stimulation for a Surgical Procedure
  178. Delayed clinical improvement after deep brain stimulation–related subdural hematoma
  179. It is time to remove the ‘benign’ from the essential tremor label
  180. Hospitalization in Parkinson disease: A survey of National Parkinson Foundation Centers
  181. Rescue leads: A salvage technique for selected patients with a suboptimal response to standard DBS therapy
  182. Alternate but Do Not Swim: A Test for Executive Motor Dysfunction in Parkinson Disease
  183. Generic versus branded pharmacotherapy in Parkinson’s disease: Does it matter? A review
  184. Lateral ventricle volume is poor predictor of post unilateral DBS motor change for Parkinson’s disease
  185. Deep brain stimulation and the role of astrocytes
  186. Comments on Selected Recent Dysphagia Literature
  187. Did General Douglas MacArthur have Parkinson disease?: A video and archival analysis
  188. Mixed results for GPi-DBS in the treatment of cranio-facial and cranio-cervical dystonia symptoms
  189. Lessons learned from a large single center cohort of patients referred for DBS management
  190. Weight Changes in Subthalamic Nucleus vs Globus Pallidus Internus Deep Brain Stimulation: Results From the COMPARE Parkinson Disease Deep Brain Stimulation Cohort
  191. Nonmotor manifestations of dystonia: A systematic review
  192. The Case for Testing Memory With Both Stories and Word Lists Prior to DBS Surgery for Parkinson's Disease
  193. Accuracy of Postoperative Computed Tomography and Magnetic Resonance Image Fusion for Assessing Deep Brain Stimulation Electrodes
  194. Steady or not following thalamic deep brain stimulation for essential tremor
  195. Do Stable Patients With a Premorbid Depression History Have a Worse Outcome After Deep Brain Stimulation for Parkinson Disease?
  196. Improving quality of care in Parkinson disease
  197. Management of the hospitalized patient with Parkinson’s disease: Current state of the field and need for guidelines
  198. The trajectory of apathy after deep brain stimulation: From pre-surgery to 6 months post-surgery in Parkinson’s disease
  199. Deep Brain Stimulation for Parkinson Disease
  200. Dr. Henry Head and lessons learned from his self-experiment on radial nerve transection
  201. Binge Eating in Parkinson's Disease: Prevalence, Correlates and the Contribution of Deep Brain Stimulation
  202. Measurement of patient-centered outcomes in Parkinson’s disease: What do patients really want from their treatment?
  203. The distal partial trisomy 1q syndrome and dystonic tremor
  204. A pilot study of human brain tissue post-magnetic resonance imaging: Information from the National Deep Brain Stimulation Brain Tissue Network (DBS-BTN)
  205. Antiphospholipid syndrome and other lupus-related movement disorders
  206. Clock Drawing in the Montreal Cognitive Assessment: Recommendations for Dementia Assessment
  207. Do patient's get angrier following STN, GPi, and thalamic deep brain stimulation
  208. Effect of Deep Brain Stimulation on Parkinson's Nonmotor Symptoms following Unilateral DBS: A Pilot Study
  209. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: What should be the policy?
  210. Patient-specific analysis of the relationship between the volume of tissue activated during DBS and verbal fluency
  211. Pre- and Post- GPi DBS Neuropsychological Profiles in a Case of X-Linked Dystonia-Parkinsonism
  212. Smile and laughter induction and intraoperative predictors of response to deep brain stimulation for obsessive-compulsive disorder
  213. The Frequency of Nonmotor Symptoms among Advanced Parkinson Patients May Depend on Instrument Used for Assessment
  214. Using Voluntary Cough To Detect Penetration and Aspiration During Oropharyngeal Swallowing in Patients With Parkinson Disease
  215. Editorial
  216. A closer look at unilateral versus bilateral deep brain stimulation: results of the National Institutes of Health COMPARE cohort
  217. Parkinson’s disease DBS: what, when, who and why? The time has come to tailor DBS targets
  218. Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: A randomized trial
  219. Parkinsonism and neurological manifestations of influenza throughout the 20th and 21st centuries
  220. Tests of dorsolateral frontal function correlate with objective tests of postural stability in early to moderate stage Parkinson’s disease
  221. Piloting the NPF data-driven quality improvement initiative
  222. Relationship between higher rates of adverse events in deep brain stimulation using standardized prospective recording and patient outcomes
  223. Disrupting abnormal electrical activity with deep brain stimulation: is epilepsy the next frontier?
  224. The impact of and the factors associated with drooling in Parkinson's disease
  225. Can exercise improve language and cognition in Parkinson's disease? A case report
  226. Lack of benefit of accumbens/capsular deep brain stimulation in a patient with both tics and obsessive–compulsive disorder
  227. Respiratory-Swallowing Coordination and Swallowing Safety in Patients with Parkinson’s Disease
  228. The national DBS brain tissue network pilot study: need for more tissue and more standardization
  229. Speech motor program maintenance, but not switching, is enhanced by left-hemispheric deep brain stimulation in Parkinson's disease
  230. Factors related to extended hospital stays following deep brain stimulation for Parkinson's disease
  231. Update on deep brain stimulation for neuropsychiatric disorders
  232. Elementary, my dear Dr. Allen: The case of barium toxicity and Pa Ping
  233. Prevalence and characteristics of punding and repetitive behaviors among Parkinson patients in North-Central Florida
  234. Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease
  235. Pseudobulbar affect: prevalence and quality of life impact in movement disorders
  236. Is Rhinorrhea an Under-Recognized Intrinsic Symptom of Parkinson Disease? A Prospective Pilot Study
  237. Knee Extensor Strength, Dynamic Stability, and Functional Ambulation: Are They Related in Parkinson's Disease?
  238. Parkinson's disease in women: A call for improved clinical studies and for comparative effectiveness research
  239. Brain penetration effects of microelectrodes and deep brain stimulation leads in ventral intermediate nucleus stimulation for essential tremor
  240. Clonazepam and Botulinum Toxin for the Treatment of Alien Limb Phenomenon
  241. Deep Brain Stimulation for Intractable Obsessive Compulsive Disorder: Pilot Study Using a Blinded, Staggered-Onset Design
  242. Identification and management of deep brain stimulation intra- and postoperative urgencies and emergencies
  243. The effect of deep brain stimulation surgery on repetitive behavior in Parkinson patients: A case series1
  244. Cognitive Declines After Unilateral Deep Brain Stimulation Surgery in Parkinson's Disease: A Controlled Study Using Reliable Change, Part II
  245. Converting the UPDRS part III to the Hoehn and Yahr staging may not be adequate for a research database
  246. DEEP BRAIN STIMULATION IN MOVEMENT DISORDERS
  247. Mood and motor effects of thalamic deep brain stimulation surgery for essential tremor
  248. A Case of Mania following Deep Brain Stimulation for Obsessive Compulsive Disorder
  249. Differential Response of Dystonia and Parkinsonism following Globus Pallidus Internus Deep Brain Stimulation in X-Linked Dystonia-Parkinsonism (Lubag)
  250. INPH and Parkinson disease: differentiation by levodopa response
  251. Prevalence of Twiddler’s Syndrome as a Cause of Deep Brain Stimulation Hardware Failure
  252. Should We Consider Vim Thalamic Deep Brain Stimulation for Select Cases of Severe Refractory Dystonic Tremor
  253. The Relationship Between Anosmia, Constipation, and Orthostasis and Parkinson's Disease Duration: Results of a Pilot Study
  254. Time for comprehensive care networks for Parkinson's disease
  255. Side onset influences motor impairments in Parkinson disease
  256. Genome-wide association study reveals genetic risk underlying Parkinson's disease
  257. Erratum to: The number and nature of emergency department encounters in patients with deep brain stimulators
  258. QUETIAPINE IMPROVES VISUAL HALLUCINATIONS IN PARKINSON DISEASE BUT NOT THROUGH NORMALIZATION OF SLEEP ARCHITECTURE: RESULTS FROM A DOUBLE-BLIND CLINICAL-POLYSOMNOGRAPHY STUDY
  259. The number and nature of emergency department encounters in patients with deep brain stimulators
  260. Gene Therapy for Neurological Disorders: Challenges and Future Prospects for the Use of Growth Factors for the Treatment of Parkinsons Disease
  261. Randomized gossip algorithms for maintaining a distributed bulletin board with guaranteed age properties
  262. Is the N-Back Task a Valid Neuropsychological Measure for Assessing Working Memory?
  263. A high resolution and high contrast MRI for differentiation of subcortical structures for DBS targeting: The Fast Gray Matter Acquisition T1 Inversion Recovery (FGATIR)
  264. Safety of MRI in patients with implanted deep brain stimulation devices
  265. Surgical Treatment of Movement Disorders
  266. An evaluation of rating scales utilized for deep brain stimulation for dystonia
  267. The relationship between quality of life and swallowing in Parkinson's disease
  268. Effects of dopaminergic medication on objective tasks of deftness, bradykinesia and force control
  269. Awareness of Expressivity Deficits in Non-Demented Parkinson Disease
  270. Startle reflex hyporeactivity in Parkinson's disease: An emotion-specific or arousal-modulated deficit?
  271. Enough Is Enough
  272. Turning off artistic ability: The influence of left DBS in art production
  273. De novo and rescue DBS leads for refractory Tourette syndrome patients with severe comorbid OCD: a multiple case report
  274. Depressive Symptoms in Parkinson Disease Correlate With Impaired Global and Specific Cognitive Performance
  275. SNCAvariants are associated with increased risk for multiple system atrophy
  276. Impact of Expiratory Muscle Strength Training on Voluntary Cough and Swallow Function in Parkinson Disease
  277. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: The COMPARE Trial
  278. Does laterality of motor impairment tell us something about cognition in Parkinson disease?
  279. Examination of the Lille Apathy Rating Scale in Parkinson disease
  280. Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus
  281. Cognitive declines one year after unilateral deep brain stimulation surgery in parkinson's disease: A controlled study using reliable change
  282. NEUROENDOCRINOLOGIC CONSIDERATIONS IN PARKINSON DISEASE AND OTHER MOVEMENT DISORDERS
  283. Perceptual characteristics of Parkinsonian speech: A comparison of the pharmacological effects of levodopa across speech and non-speech motor systems
  284. Mood and energy determinants of quality of life in dystonia
  285. Subjective perception of cognition is related to mood and not performance
  286. Brain penetration effects of microelectrodes and DBS leads in STN or GPi
  287. A punder in Catch-22
  288. Tardive parkinsonism in a bipolar patient: Post-mortem examination supports a physiological rather than pathological dysfunction
  289. Artistic creativity and DBS: A case report
  290. Deep Brain Stimulation for Tremor
  291. Failed DBS for palliation of visual problems in a case of oculopalatal tremor
  292. Inappropriate crying and laughing in Parkinson disease and movement disorders
  293. Neuropsychological Profile of a Filipino Gentleman with X-Linked Dystonia–Parkinsonism: A Case Report of Lubag Disease
  294. Tracing the Origin of L-2-Hydroxyglutaric Aciduria in a Family
  295. Deep brain stimulation of the ventral intermediate nucleus of the thalamus in medically refractory orthostatic tremor: Preliminary observations
  296. ALBERT SIDNEY JOHNSTON'S SCIATIC DUELING INJURY DID NOT CONTRIBUTE TO HIS DEATH AT THE BATTLE OF SHILOH
  297. Venous Air Embolism in Deep Brain Stimulation
  298. REOPERATION FOR SUBOPTIMAL OUTCOMES AFTER DEEP BRAIN STIMULATION SURGERY
  299. The persistent effects of unilateral pallidal and subthalamic deep brain stimulation on force control in advanced Parkinson's patients
  300. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience
  301. Avoiding deep brain stimulation failures in Tourette syndrome
  302. Renaming in synchronous message passing systems with Byzantine failures
  303. Role of deep brain stimulation targeted to the pedunculopontine nucleus in Parkinson’s disease
  304. Punding as a Complication of Brain Stem Stroke?
  305. The ???Chair Test??? to Aid in the Diagnosis of Psychogenic Gait Disorders
  306. Stochastic Emergence of Repeating Cortical Motifs in Spontaneous Membrane Potential Fluctuations In Vivo
  307. Deep Brain Stimulation and the Role of the Neuropsychologist
  308. Comprehensive Screening of a North American Parkinson’s Disease Cohort for LRRK2 Mutation
  309. Depression symptoms in movement disorders: Comparing Parkinson's disease, dystonia, and essential tremor
  310. Limb-kinetic apraxia in Parkinson disease
  311. LRRK2 mutations in a clinic-based cohort of Parkinson's disease
  312. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data
  313. Faces of emotion in Parkinsons disease: Micro-expressivity and bradykinesia during voluntary facial expressions
  314. Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming
  315. Deep Brain Stimulation of the Internal Segment of the Globus Pallidus in Delayed Runaway Dyskinesia
  316. Three-Year Outcomes in Deep Brain Stimulation for Highly Resistant Obsessive–Compulsive Disorder
  317. Long-term Habituation of the Smile Response with Deep Brain Stimulation
  318. Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli
  319. The human prion gene M129V polymorphism is not associated with idiopathic Parkinson's disease in three distinct populations
  320. Paraneoplastic chorea with leukoencephalopathy presenting with obsessive-compulsive and behavioral disorder
  321. Multiplicative multifractal modeling and discrimination of human neuronal activity
  322. Management of Referred Deep Brain Stimulation Failures
  323. Panic and fear induced by deep brain stimulation
  324. Subthalamic Nucleus vs Globus Pallidus Interna Deep Brain Stimulation, the Rematch
  325. Ventralis Intermedius plus Ventralis Oralis Anterior and Posterior Deep Brain Stimulation for Posttraumatic Holmes Tremor: Two Leads May Be Better than One: Technical Note
  326. Staged Deep Brain Stimulation for Refractory Craniofacial Dystonia with Blepharospasm: Case Report and Physiology
  327. Agreement Among Unacquainted Byzantine Generals
  328. Deep brain stimulation of the GPi treats restless legs syndrome associated with dystonia
  329. Stimulation of the Subthalamic Nucleus in a Patient With Parkinson Disease and Essential Tremor
  330. The neurochemical mechanism of rebound psychosis in Parkinson's disease
  331. Analysis of the PINK1 Gene in a Large Cohort of Cases With Parkinson Disease
  332. Alien limb syndrome and moya-moya disease
  333. A Mnemonic for Parkinson Disease Patients Considering DBS: A Tool to Improve Perceived Outcome of Surgery
  334. Dystonia, tremor, and parkinsonism in a 54 year old man with 2-hydroxyglutaric aciduria
  335. Psychosis in Parkinson’s Disease
  336. Rebound psychosis: Effect of discontinuation of antipsychotics in Parkinson's disease
  337. Magnetic Resonance Imaging of the Posterior Columns in Vitamin B12 Deficiency
  338. What's in a “Smile?” Intra-operative Observations of Contralateral Smiles Induced by Deep Brain Stimulation
  339. Pseudobulbar crying induced by stimulation in the region of the subthalamic nucleus
  340. Atomic Writes for data integrity and consistency in shared storage devices for clusters
  341. Babinski's Clinical Differentiation of Organic Paralysis From Hysterical Paralysis
  342. SANDO: another presentation of mitochondrial disease
  343. Aphasia and Thalamotomy: Important Issues
  344. Lesion therapy for Parkinson's disease and other movement disorders: Update and controversies
  345. A new approach for approximating node deletion problems
  346. Mood changes with deep brain stimulation of STN and GPi: results of a pilot study
  347. Radiosurgery Can Achieve Precision Needed for Functional Neurosurgery
  348. Huntington???s Disease: What We Learned From the Original Essay
  349. Transient manic behavior after pallidotomy
  350. Beneficial Effects of Testosterone Replacement for the Nonmotor Symptoms of Parkinson Disease
  351. Gamma Knife Thalamotomy for Disabling Tremor
  352. Immobilization dystonia
  353. Not Our Knife: Gamma Knife Surgery for Parkinson Disease
  354. Treatment of pseudobulbar laughter after gamma knife thalamotomy
  355. Origins of the Sensory Examination in Neurology
  356. Antiphospholipid- associated recurrent chorea and ballism in a child with cerebral palsy
  357. Linear Predictive Analysis for Targeting the Basal Ganglia in Deep Brain Stimulation Surgeries